国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant 5,10-methenyltetrahydromethanopterin hydrogenase (hmd) CSB-YP330164MRQ
CSB-EP330164MRQ
CSB-BP330164MRQ
CSB-MP330164MRQ
CSB-EP330164MRQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Single-stranded DNA-binding protein RIM1, mitochondrial (RIM1) CSB-YP330165SVG
CSB-EP330165SVG
CSB-BP330165SVG
CSB-MP330165SVG
CSB-EP330165SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Biotin synthase, mitochondrial (BIO2) CSB-YP330166SVG
CSB-EP330166SVG
CSB-BP330166SVG
CSB-MP330166SVG
CSB-EP330166SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Cell division control protein 11 (CDC11) CSB-YP330167SVG
CSB-EP330167SVG
CSB-BP330167SVG
CSB-MP330167SVG
CSB-EP330167SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Acyl carrier protein, mitochondrial (ACP1) CSB-YP330168SVG
CSB-EP330168SVG
CSB-BP330168SVG
CSB-MP330168SVG
CSB-EP330168SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aphanocladium album Chitinase 1 (CHI1) CSB-YP330169AMB
CSB-EP330169AMB
CSB-BP330169AMB
CSB-MP330169AMB
CSB-EP330169AMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Para-aminobenzoate synthase (pab), partial CSB-YP330170SUW
CSB-EP330170SUW
CSB-BP330170SUW
CSB-MP330170SUW
CSB-EP330170SUW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae ATPase expression protein 1, mitochondrial (AEP1) CSB-YP330171SVG
CSB-EP330171SVG
CSB-BP330171SVG
CSB-MP330171SVG
CSB-EP330171SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Nucleoporin NUP2 (NUP2), partial CSB-YP330172SVG
CSB-EP330172SVG
CSB-BP330172SVG
CSB-MP330172SVG
CSB-EP330172SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Nuclear polyadenylated RNA-binding protein NAB2 (NAB2), partial CSB-YP330173SVG
CSB-EP330173SVG
CSB-BP330173SVG
CSB-MP330173SVG
CSB-EP330173SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Equine herpesvirus 1 Envelope protein US9 homolog (76), partial CSB-YP330174EFM1
CSB-EP330174EFM1
CSB-BP330174EFM1
CSB-MP330174EFM1
CSB-EP330174EFM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Pre-mRNA-splicing factor 19 (PRP19), partial CSB-YP330175SVG
CSB-EP330175SVG
CSB-BP330175SVG
CSB-MP330175SVG
CSB-EP330175SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human parainfluenza 1 virus Phosphoprotein (P/C), partial CSB-YP330176HOW
CSB-EP330176HOW
CSB-BP330176HOW
CSB-MP330176HOW
CSB-EP330176HOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human adenovirus F serotype 41 Hexon-associated protein (PIX) CSB-YP330177HIS
CSB-EP330177HIS
CSB-BP330177HIS
CSB-MP330177HIS
CSB-EP330177HIS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rotavirus A Outer capsid glycoprotein VP7 CSB-YP330178RGH
CSB-EP330178RGH
CSB-BP330178RGH
CSB-MP330178RGH
CSB-EP330178RGH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African horse sickness virus 4 Outer capsid protein VP2 (S2), partial CSB-YP330179ADZ
CSB-EP330179ADZ
CSB-BP330179ADZ
CSB-MP330179ADZ
CSB-EP330179ADZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Protein SNQ2 (SNQ2), partial CSB-YP330180SVG
CSB-EP330180SVG
CSB-BP330180SVG
CSB-MP330180SVG
CSB-EP330180SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Meiosis induction protein kinase IME2/SME1 (IME2), partial CSB-YP330181SVG
CSB-EP330181SVG
CSB-BP330181SVG
CSB-MP330181SVG
CSB-EP330181SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Serine/threonine-protein kinase TOR2 (TOR2), partial CSB-YP330182SVG
CSB-EP330182SVG
CSB-BP330182SVG
CSB-MP330182SVG
CSB-EP330182SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Chromatin-remodeling complex subunit IES6 (IES6) CSB-YP330183SVG
CSB-EP330183SVG
CSB-BP330183SVG
CSB-MP330183SVG
CSB-EP330183SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>